ORCHARD THERAPEUTICS PLC Basic Shares Outstanding (Weighted Average)
ORCHARD THERAPEUTICS PLC reported Basic Shares Outstanding (Weighted Average) of 228.39 billion shares for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC weighted average number of shares outstanding, basic for the quarter ending 2023-09-30 was 228.39B shares, a 78.24% increase year-over-year.
- ORCHARD THERAPEUTICS PLC weighted average number of shares outstanding, basic for the quarter ending 2023-06-30 was 189.29M shares, a 48.05% increase year-over-year.
- ORCHARD THERAPEUTICS PLC weighted average number of shares outstanding, basic for the quarter ending 2023-03-31 was 141.81M shares, a 11.05% increase year-over-year.
- ORCHARD THERAPEUTICS PLC weighted average number of shares outstanding, basic for the quarter ending 2022-12-31 was -383.17B shares, a 300491.10% decline year-over-year.
- ORCHARD THERAPEUTICS PLC weighted average number of shares outstanding, basic for fiscal 2022 was 127.98M shares, a 3.24% increase from fiscal 2021.
- ORCHARD THERAPEUTICS PLC weighted average number of shares outstanding, basic for fiscal 2021 was 123.96M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2023-09-30 | 228.39B shares 10-Q · filed 2023-11-13 | 114.29B shares derived: average of 2 quarters · filed 2023-11-13 | 186.81B shares 10-Q · filed 2023-11-13 | -38.61B shares derived: average of 4 quarters · filed 2023-11-13 | ||
| 2023-06-30 | 189.29M shares 10-Q · filed 2023-08-10 | 165.48M shares 10-Q · filed 2023-08-10 | -127.61B shares derived: average of 3 quarters · filed 2023-08-10 | -63.68B shares derived: average of 4 quarters · filed 2023-11-13 | ||
| 2023-03-31 | 141.81M shares 10-Q · filed 2023-05-15 | -191.52B shares derived: average of 2 quarters · filed 2023-05-15 | -84.97B shares derived: average of 3 quarters · filed 2023-11-13 | -63.69B shares derived: average of 4 quarters · filed 2023-11-13 | ||
| 2022-12-31 | -383.17B shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -127.52B shares derived: average of 2 quarters · filed 2023-11-13 | -84.97B shares derived: average of 3 quarters · filed 2023-11-13 | 127.98M shares 10-K · filed 2023-03-14 | ||
| 2022-09-30 | 128.13B shares 10-Q · filed 2023-11-13 | 128.13M shares 10-Q · filed 2022-11-14 | 64.13B shares derived: average of 2 quarters · filed 2023-11-13 | 127.90B shares 10-Q · filed 2023-11-13 | 127.90M shares 10-Q · filed 2022-11-14 | 32.13B shares derived: average of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | 127.85M shares 10-Q · filed 2023-08-10 | 127.78M shares 10-Q · filed 2023-08-10 | 127.70M shares derived: average of 3 quarters · filed 2023-08-10 | 127.62M shares derived: average of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | 127.69M shares 10-Q · filed 2023-05-15 | 127.63M shares derived: average of 2 quarters · filed 2023-05-15 | 127.54M shares derived: average of 3 quarters · filed 2023-05-15 | 127.15M shares derived: average of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | 127.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | 127.47M shares derived: average of 2 quarters · filed 2023-03-14 | 126.96M shares derived: average of 3 quarters · filed 2023-03-14 | 123.96M shares 10-K · filed 2023-03-14 | ||
| 2021-09-30 | 127.38M shares 10-Q · filed 2022-11-14 | 126.66M shares derived: average of 2 quarters · filed 2022-11-14 | 122.77M shares 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | 125.95M shares 10-Q · filed 2022-08-04 | 120.42M shares 10-Q · filed 2022-08-04 |